Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × Tumor Response Rate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 464 Neoplasms 345 Prostatic Neoplasms 224 Colorectal Neoplasms 222 Lung Neoplasms 177 Carcinoma, Hepatocellular 155 Stomach Neoplasms 144 Pancreatic Neoplasms 138 Rectal Neoplasms 125 Colonic Neoplasms 108 Carcinoma, Non-Small-Cell Lung 107 Motor Activity 106 Uterine Cervical Neoplasms 99 Head and Neck Neoplasms 88 Polycystic Ovary Syndrome 85 Esophageal Neoplasms 76 Liver Neoplasms 63 Brain Neoplasms 63 Neoplasm Metastasis 61 Ovarian Neoplasms 55 Urinary Bladder Neoplasms 54 Recurrence 54 Fatigue 50 Pain 48 Melanoma 46 Endometrial Neoplasms 46 Thyroid Neoplasms 42 Anxiety Disorders 41 Lymphoma 40 Pain, Postoperative 37

Interventions

Sirtuins 1 Radiotherapy, Conformal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03910140 2019-04-10

TILA-TACE in Treatment of Hepatocellular Carcinoma

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase NA Unknown

Tumor Response Rate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡